Rapid7 Earnings: What To Look For From RPD

Rapid7 (NASDAQ:RPD) reports earnings Monday after the bell. Last quarter, it posted revenue of $209.7M, flat year over year, and beat analysts’ revenue expectations; adjusted operating income also exceeded estimates. For the current quarter, analysts expect revenue to fall 2.9% y/y. The article cites peer results from Qualys and Tenable and notes RPD’s recent price target of $8.32 vs $11.59.

Original reporting
Published Aug 9, 2026, 3:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 3:55 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rapid7 Earnings: What To Look For From RPD — source image
Decision brief

The 30-second read

$RPDNeutralMed
01

Why it matters

The main actionable element is the stated consensus setup: revenue expected to decline 2.9% YoY, with analysts largely reconfirming estimates over the last 30 days.

02

Market read

This is an earnings preview for RPD with consensus direction and peer read-through, but no new company-specific disclosure beyond the scheduled reporting timing.

03

What to watch

The article does not include guidance, margin trajectory, or backlog/ARR metrics, which are often the real drivers of post-earnings repricing for software names.

Relevance 5/10Novelty 4/10Timing: ahead of Monday after-the-bell earnings

Background

The piece frames Rapid7’s upcoming earnings as a test of whether recent momentum persists, referencing last quarter’s revenue and adjusted operating income performance.

Company-level read

Ticker impact

$RPDNeutralMedium confidence
Context

Rapid7 (RPD) reports earnings Monday after the bell, with the article citing revenue expectations and prior quarter beat details.

Expected impact

Near-term volatility likely around the after-hours earnings print, with upside/downside driven by whether revenue decline is smaller than expected and adjusted operating income holds up.

Evidence & confidence

The article provides consensus direction (revenue -2.9% YoY) and notes a prior revenue beat and adjusted operating income beat, but it does not disclose new guidance or a fresh catalyst beyond the scheduled report.

Market effects

Cybersecurity peers’ recent results (Qualys, Tenable) are used as read-through, potentially shaping expectations for Rapid7’s segment.

No specific regional impact described.

No explicit global macro or cross-border catalyst described.

Counterpoint

If investors are already positioned for a beat based on prior history, the stock could sell off on any confirmation of the expected YoY revenue decline.

Key entities

  • Rapid7

    NASDAQ-listed cybersecurity software provider reporting results Monday after the bell.

  • Qualys

    Peer cited as having delivered YoY revenue growth and a post-results stock jump.

  • Tenable

    Peer cited as having topped revenue expectations and risen after results.

Related articles

$OFIXMed

These 7 Small Caps Are On Fire In July: Here's Why - ExxonMobil Holdings (NYSE:XOM), Vertex Pharmaceutica

The Russell 2000 stayed near 3,000 with little movement, while seven small-cap stocks gained at least 28% in four sessions. The article cites July surges for Orthofix (OFIX) on CMS reimbursement reversal, REGENXBIO (RGNX) on FDA resubmission alignment and AbbVie milestone, Verastem (VSTM) on short-squeeze setup, ADC Therapeutics (ADCT) rebound, Sable Offshore (SOC) refinancing, Rapid7 (RPD) takeover speculation, and Crinetics (CRNX) surge toward an offer price.

$RPDMedAI 8/10

Rapid7 (RPD) Stock Trades Down, Here Is Why

Rapid7 (NASDAQ: RPD) shares fell 11.3% in the morning after Morgan Stanley downgraded the stock from Equal Weight to Underweight and kept a $9 price target. The firm cited competitive pressure in vulnerability management from AI-focused rivals and said Rapid7 has lagged in exposure management and real-time remediation. RPD is down 26.5% YTD.

$RPDMedAI 8/10

Rapid7 (RPD) Releases Findings of Q1 Threat Landscape Report

Rapid7 (NASDAQ:RPD) released its Q1 2026 Threat Landscape Report on May 21, citing vulnerability exploitation as 38% of incident response cases. The company said AI is speeding attackers’ ability to identify and exploit unpatched systems. Separately, Barclays lowered its price target and kept an Underweight rating after Rapid7’s Q1 results, citing weaker-than-expected Q2 ARR guidance. Rapid7 projects Q2 ARR of about $820M versus $832M in Q1.

$ROADMed

Construction Partners, Inc. Q3 2026 Earnings Call Summary

Construction Partners, Inc. reported Q3 2026 results driven by cost pass-through amid energy inflation and unusually wet weather. Management said Sunbelt demand tied to AI data centers and acquisitions support growth. Fiscal 2026 guidance was raised to over 30% revenue and margin growth, with 75% to 85% EBITDA to operating cash flow and leverage targeting 2.5x.

$RXOMed

RXO Q2 Earnings Call Highlights

RXO (NYSE:RXO) reported Q2 spot freight rising to 42% of truckload volume, up 900 bps sequentially and 1,500 bps YoY. Truckload gross profit per load rose 11% sequentially, while brokerage margin fell 70 bps to 10.7% on higher fuel. Complementary services revenue rose 7% to $488M. Q3 adjusted EBITDA guidance is $35M to $45M; adjusted free cash flow was -$42M in Q2.